GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (OTCPK:WXXWY) » Definitions » Change In Inventory

WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Change In Inventory : $0 Mil (TTM As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Change In Inventory?

WuXi Biologics (Cayman)'s change in inventory for the quarter that ended in Jun. 2023 was $0 Mil. It means WuXi Biologics (Cayman)'s inventory stayed the same from Dec. 2022 to Jun. 2023 .

WuXi Biologics (Cayman)'s change in inventory for the fiscal year that ended in Dec. 2022 was $-71 Mil. It means WuXi Biologics (Cayman)'s inventory increased by $71 Mil from Dec. 2021 to Dec. 2022 .

WuXi Biologics (Cayman)'s Total Inventories for the quarter that ended in Jun. 2023 was $274 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. WuXi Biologics (Cayman)'s Days Inventory for the quarter that ended in Jun. 2023 was 79.72.

Inventory Turnover measures how fast the company turns over its inventory within a year. WuXi Biologics (Cayman)'s Inventory Turnover for the quarter that ended in Jun. 2023 was 2.29.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. WuXi Biologics (Cayman)'s Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.25.


WuXi Biologics (Cayman) Change In Inventory Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Change In Inventory Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.40 -107.74 -122.96 -71.45 -

WuXi Biologics (Cayman) Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

WuXi Biologics (Cayman) Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi Biologics (Cayman)  (OTCPK:WXXWY) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

WuXi Biologics (Cayman)'s Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=300.7865/688.61*365 / 2
=79.72

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

WuXi Biologics (Cayman)'s Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

WuXi Biologics (Cayman)'s Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi Biologics (Cayman) Change In Inventory Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Business Description

Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.